Drug Shortage Report for BEXSERO
| Report ID | 63383 |
| Drug Identification Number | 02417030 |
| Brand name | BEXSERO |
| Common or Proper name | Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | Recombinant Neisseria meningitidis group B NHBA fusion protein Recombinant Neisseria meningitidis group B NadA protein Recombinant Neisseria meningitidis group B fHBP fusion protein Outer membrane vesicles |
| Strength(s) | 50MCG 50MCG 50MCG 25MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07AH |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-10-01 |
| Estimated end date | 2018-12-06 |
| Actual end date | 2018-10-29 |
| Shortage status | Resolved |
| Updated date | 2018-10-31 |
| Company comments | Supply disruptions may be seen in the private market for packages of 1. Product under allocation. BEXSERO is available in packages of 10. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-10-31 | French | Compare |
| v5 | 2018-10-31 | English | Compare |
| v4 | 2018-10-26 | French | Compare |
| v3 | 2018-10-26 | English | Compare |
| v2 | 2018-10-05 | French | Compare |
| v1 | 2018-10-05 | English | Compare |
Showing 1 to 6 of 6